Unknown NA INTERVENTIONAL NCT00136929

Senior PAMI: Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly

A Prospective Randomized Trial of Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly Senior PAMI

Sponsor: Eli Lilly and Company

Conditions Myocardial Infarction

Interventions Percutaneous coronary intervention (PCI) Thrombolytic therapy

Updated 5 times since 2017 Last updated: Dec 12, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Myocardial Infarction and is currently ongoing. Eli Lilly and Company leads this study, which shows 5 recorded versions since 2026 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eli Lilly and Company
Guidant Corporation
PAMI Coordinating Center

Data source: PAMI Coordinating Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.